Tyrosine kinase-IN-8
Tyrosine kinase-IN-8 (compound 4e) is a BCR‐ABL1 tyrosine kinase inhibitor (TKI). Tyrosine kinase-IN-8 shows anti-proliferative activity against K562 cells, a chronic myeloid leukemia (CML) cell line (CC50=0.8 µM). Tyrosine kinase-IN-8 can be used in the study of chronic leukemia.
For research use only. We do not sell to patients.
- Formula: C31H21F2N7O2
- Molecular Weight:561.54
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Abl1 0.8 μM (CC50) |
Tyrosine kinase-IN-8 (1 and 10 µM, 48 h) shows the best anti-leukemia activity in the K562 cell lines, but is also more toxic to WSS-1 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:K562 cells and WSS-1 cells
-
Concentration:1 and 10 µM
-
Incubation Time:48 h
-
Result:Reduced cell activity at 10μM but had no obvious cytotoxicity at 1μM.
Chemical Information
-
Molecular Weight 561.54
-
Formula C31H21F2N7O2
-
SMILES
CC(C=CC(N1C(C2=CC=C(F)C=C2)=NOC13C(C=C(F)C=C4)=C4NC3=O)=C5)=C5NC6=NC(C7=CC=CN=C7)=CC=N6
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)